Stocks and Investing Stocks and Investing
Tue, April 20, 2021
Mon, April 19, 2021

David Lewis Maintained (BVS) at Buy with Increased Target to $19 on, Apr 19th, 2021


Published on 2024-10-27 16:18:16 - WOPRAI, David Lewis
  Print publication without navigation


David Lewis of Morgan Stanley, Maintained "Bioventus Inc." (BVS) at Buy with Increased Target from $18 to $19 on, Apr 19th, 2021.

David has made no other calls on BVS in the last 4 months.



There are 3 other peers that have a rating on BVS. Out of the 3 peers that are also analyzing BVS, 0 agree with David's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with David


  • Amit Hazan of "Goldman Sachs" Initiated at Strong Buy and Held Target at $19 on, Monday, March 8th, 2021
  • Kyle Rose of "Canaccord Genuity" Initiated at Strong Buy and Held Target at $23 on, Monday, March 8th, 2021
  • Robbie Marcus of "JP Morgan" Initiated at Buy and Held Target at $17 on, Monday, March 8th, 2021
Contributing Sources